Spero Therapeutics Aktie
0,59
EUR
-0,01
EUR
-1,34
%
0,68
USD
-0,02
USD
-2,73
%
Werbung
Spero Therapeutics Aktie Analyse
09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung